// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "PMID technical replicate replicate collision energy VK cell type CT WILL MIAME MS:1001251 CS USE CN INFORMATION TIP dissociation method RIGHTS exclamation PRM instrument SWATH data file CLO WARRANTY ZFA MAGE IDF sample URI EXPRESS REQUIRES SILAC ALL PROTEOMICS XL HEREIN NOTE CF CELL RAW NOT DJ biosample accession number label SHALL SRM ID depletion reduction reagent age file your disease stage STANDARDS LI LC HANCESTRO FITNESS PP HF QY EBI biological replicate XML NCBI PARTICULAR cleavage agent details PRIDE sex source name_ and _assay name developmental stage PS HCD PSI PO NT IS INFRINGE II MT PTM CPTAC INCLUDING SH DTT COLUMN MUST ... FDR MANDATORY disease HUPO HTML SHOULD SP mass MOD NCE THE MHC LIMITED OPTIONAL README OR MS MAY EW IMPLIED TAB MINOR IAA AC COULD DDA MONDO PURPOSE MAJOR BTO III EM spiked compound PATO MERCHANTABILITY MC ROW AS source name BUT RECOMMEND SDRF proteomics data acquisition method PMCID TMT DIA VCF PATCH ancestry category TO organism JA INITIATIVE CL characteristics RFC alkylation reagent PRIDE:0000659 EFO CID OF ISA BMC fractionation method REQUIRED CV THAT TA PEPTIDESEQ URL DISCLAIMS organism part BE fraction identifier individual IMPORTANT WARRANTIES pooled sample SN FOR BRENDA RECOMMENDED ANY DOID ENVO UBERON"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "PMID technical replicate collision energy VK cell type CT WILL MIAME MS:1001251 CS USE CN INFORMATION dissociation method RIGHTS PRM instrument SWATH data file CLO WARRANTY ZFA MAGE IDF URI EXPRESS REQUIRES SILAC ALL PROTEOMICS XL HEREIN CF CELL RAW NOT DJ biosample accession number label SHALL SRM depletion reduction reagent age disease stage STANDARDS LI LC HANCESTRO FITNESS PP HF QY EBI biological replicate NCBI PARTICULAR cleavage agent details PRIDE sex PS HCD PSI PO NT IS INFRINGE II MT PTM CPTAC INCLUDING SH DTT COLUMN MUST ... FDR MANDATORY disease HUPO HTML SHOULD SP mass MOD NCE THE MHC LIMITED OPTIONAL README OR MS MAY EW IMPLIED TAB MINOR IAA AC COULD DDA MONDO PURPOSE MAJOR BTO III EM spiked compound PATO MERCHANTABILITY MC ROW AS BUT RECOMMEND SDRF proteomics data acquisition method PMCID TMT DIA VCF PATCH ancestry category TO organism JA INITIATIVE CL RFC alkylation reagent PRIDE:0000659 EFO CID OF ISA BMC fractionation method REQUIRED CV THAT TA PEPTIDESEQ URL DISCLAIMS organism part BE fraction identifier individual WARRANTIES pooled sample SN FOR BRENDA RECOMMENDED ANY DOID ENVO UBERON"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "CL:0000066 MONDO:0005180 CSF cell type UBERON:0000310 MONDO:0005301 MONDO:0005105 TIP exclamation CL:0000182 CL:0000576 CL:0000233 UBERON:0000948 MONDO:0004989 ALL CL:0000232 PATO:0000384 UBERON:0001977 COVID MONDO:0100096 UBERON:0002113 CL:0000623 NOTE UBERON:0001359 CL:0000898 NSG UBERON:0000178 ID CL:0000913 depletion age UBERON:0001155 MONDO:0004975 PATO:0000461 UBERON:0001969 HANCESTRO biological replicate NCBI sex synthetic peptide developmental stage PATO:0001340 UBERON:0001088 PO UBERON:0002107 UBERON PTM MUST CL:0000451 CL:0000236 disease compound enrichment process PATO:0000383 SHOULD DSS MONDO:0005138 UBERON:0000955 CL:0000815 CL:0000625 APP CL:0000813 disease model MAY CML MONDO xenograft lib CL:0000624 PATO NK source name MONDO:0005575 SDRF CL:0000788 ancestry category organism CL CL:0000057 EFO CL:0000787 UBERON:0002097 URL organism part individual IMPORTANT PDX MONDO:0005148 MONDO:0004946 CL:0000235 UBERON:0002048 DOID CL:0000084 CL:0000540 MONDO:0008383"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "CL:0000066 MONDO:0005180 CSF cell type UBERON:0000310 MONDO:0005301 MONDO:0005105 CL:0000182 CL:0000576 CL:0000233 UBERON:0000948 MONDO:0004989 ALL CL:0000232 PATO:0000384 UBERON:0001977 COVID MONDO:0100096 UBERON:0002113 CL:0000623 UBERON:0001359 CL:0000898 NSG UBERON:0000178 ID CL:0000913 depletion age UBERON:0001155 MONDO:0004975 PATO:0000461 UBERON:0001969 HANCESTRO biological replicate NCBI sex synthetic peptide developmental stage PATO:0001340 UBERON:0001088 PO UBERON:0002107 UBERON PTM MUST CL:0000451 CL:0000236 disease compound enrichment process PATO:0000383 SHOULD DSS MONDO:0005138 UBERON:0000955 CL:0000815 CL:0000625 APP CL:0000813 disease model MAY CML MONDO xenograft CL:0000624 PATO NK source name MONDO:0005575 SDRF CL:0000788 ancestry category organism CL CL:0000057 EFO CL:0000787 UBERON:0002097 URL organism part individual PDX MONDO:0005148 MONDO:0004946 CL:0000235 UBERON:0002048 DOID CL:0000084 CL:0000540 MONDO:0008383"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "NCI dose PR MONDO:0005300 alcohol consumption pregnancy status NCIT:C18058 time post treatment MONDO:0004979 treatment status CHEBI:28748 exclamation height gestational age NCIT:C53556 diet NCIT:C27966 NCIT:C16358 GDPR HANCESTRO:0009 NCIT:C28077 NCIT:C15632 NCIT:C81328 TNM staging UO NOTE PD sampling time point TNM body mass index NCIT:C65108 NCIT:C65106 weight Dukes stage CHEBI:41774 ID CHEBI:6801 age NCIT:C15445 disease stage smoking status NCIT:C27971 HANCESTRO menopausal status treatment treatment response sex NCIT:C28079 HANCESTRO:0010 II secondary condition NCIT:C14167 NCIT:C53554 NCIT:C28076 HANCESTRO:0005 MONDO:0005044 disease compound NCIT:C14169 PREFERRED tumor grade HIPAA breast cancer subtype NCIT:C81327 MONDO NCIT:C14174 NCIT:C65107 NCIT:C14168 MONDO:0011122 III ACE NCIT:C53553 NCIT:C28054 SDRF NCIT CHEBI:27899 NCIT:C62723 pre-existing condition ancestry category MONDO:0002050 organism NCIT:C27970 ethnicity NCIT:C18213 prior treatment NCIT:C15329 NCIT:C15262 EFO NCIT:C15313 NCIT:C18206 NCIT:C4870 MONDO:0004995 organism part individual medication history IMPORTANT AJCC IV MONDO:0005148 Ann Arbor stage ER NCIT:C28078 NCIT:C71732 NCIT:C53555 HANCESTRO:0006 BMI NCIT:C68804"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "NCI dose PR MONDO:0005300 alcohol consumption pregnancy status NCIT:C18058 time post treatment MONDO:0004979 treatment status CHEBI:28748 height gestational age NCIT:C53556 diet NCIT:C27966 NCIT:C16358 GDPR HANCESTRO:0009 NCIT:C28077 NCIT:C15632 NCIT:C81328 TNM staging UO PD sampling time point TNM body mass index NCIT:C65108 NCIT:C65106 weight Dukes stage CHEBI:41774 ID CHEBI:6801 age NCIT:C15445 disease stage smoking status NCIT:C27971 HANCESTRO menopausal status treatment treatment response sex NCIT:C28079 HANCESTRO:0010 II secondary condition NCIT:C14167 NCIT:C53554 NCIT:C28076 HANCESTRO:0005 MONDO:0005044 disease compound NCIT:C14169 PREFERRED tumor grade HIPAA breast cancer subtype NCIT:C81327 MONDO NCIT:C14174 NCIT:C65107 NCIT:C14168 MONDO:0011122 III ACE NCIT:C53553 NCIT:C28054 SDRF NCIT CHEBI:27899 NCIT:C62723 pre-existing condition ancestry category MONDO:0002050 organism NCIT:C27970 ethnicity NCIT:C18213 prior treatment NCIT:C15329 NCIT:C15262 EFO NCIT:C15313 NCIT:C18206 NCIT:C4870 MONDO:0004995 organism part individual medication history AJCC IV MONDO:0005148 Ann Arbor stage ER NCIT:C28078 NCIT:C71732 NCIT:C53555 HANCESTRO:0006 BMI NCIT:C68804"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "file uri DIA label SHOULD SRM MS:1001313 technical replicate ID TS UNIMOD:4 MOD MS:1001917 ELISA fragment mass tolerance MS:1001251 CS UNIMOD proteomexchange accession number UNIMOD:1 UNIMOD:21 RPPA TIP exclamation MS PRM instrument data file PP TOF FTP HF PRIDE:0000663 AC ST sample URI DDA REQUIRED MSD UNIMOD:35 cleavage agent details PRIDE SILAC KR TA SCIEX scan window upper limit MGF URL XL fraction identifier MRM PSI IMPORTANT UNIMOD:737 proteomics data acquisition method MS:1001303 NT MT scan window lower limit precursor mass tolerance CF NOTE fraction RECOMMENDED RAW MS1 scan range MS:1001306 modification parameters SDRF LTQ MUST MS:1001309 MS2 analyzer type TMT MM"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "file uri DIA label SHOULD SRM MS:1001313 technical replicate ID TS UNIMOD:4 MOD MS:1001917 ELISA fragment mass tolerance MS:1001251 CS UNIMOD proteomexchange accession number UNIMOD:1 UNIMOD:21 RPPA MS PRM instrument data file PP TOF FTP HF PRIDE:0000663 AC ST URI DDA REQUIRED MSD UNIMOD:35 cleavage agent details PRIDE SILAC KR TA SCIEX scan window upper limit MGF URL XL fraction identifier MRM PSI UNIMOD:737 proteomics data acquisition method MS:1001303 NT MT scan window lower limit precursor mass tolerance CF RECOMMENDED RAW MS1 scan range MS:1001306 modification parameters SDRF LTQ MUST MS:1001309 MS2 analyzer type TMT MM"
  }
];
